← Eichor
Study identifier: NCT05928169 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Determinants of Chronic Inflammatory Skin Disease Trajectories

Condition: Atopic Dermatitis · Psoriasis · Lichen Planus  ·  Sponsor: University Hospital Schleswig-Holstein

PhaseN/A
Planned participants1000
Who can joinAll sexes, 0 Years to 80 Years
Healthy volunteersYes

About this study

Although it is well known that the clinical expression and course of chronic inflammatory skin diseases are highly variable, there are insufficient epidemiological data on this, and the factors that determine the manifestation, clinical features and course are also largely unknown. There are currently no reliable markers that could predict or delineate patient subgroups to support patient management. The aim of this project is to identify clinical and molecular factors that correlate with disease, disease subtypes and progression through in-depth long-term clinical characterization of patients with chronic inflammatory skin diseases and examination of individual biomaterials.

This description comes directly from the study's public registry record.

Talk to the study team

Stephan Weidinger, MD  ·  0049431500  ·  sweidinger@dermatology.uni-kiel.de

Stefanie Sievers  ·  0049431500  ·  ssievers@dermatology.uni-kiel.de

Always discuss trial participation with your own doctor first.

Locations (1)

Department of Dermatology and Allergy, University Hospital Schleswig-HolsteinKiel, GermanyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05928169